ESG

Partner Content

CinnaGen Enters EU Market with EMA Approval for Zandoriah®

Partner Content

Revealing the human and business cost of clinical trial inefficiencies for Data Managers and CRAs

Partner Content

Mastering compliance and copyright in healthcare and MedComms

Partner Content

Driving bioscience innovation: How Teesside University empowers industry breakthroughs

News

JP Morgan 2025: Jazz Pharmaceuticals focusing on oncology pipeline

News

Study finds restrictive clinical trial criteria excludes Lyme disease patients

News

Percheron plans to broaden pipeline following avicursen disappointment

News

Xgene’s non-opioid analgesic reduces pain in Phase IIb trial

News

Zepbound will dominate obesity market following SURMOUNT-5 results, says analyst

News

First blood-stage malaria vaccine ‘a much-needed addition’ – analyst

News

APAC leading in Parkinson’s disease clinical trials

News

CEPI funds safety project for vaccines in Africa

News

Generative AI has ‘potential to revolutionise clinical development’

News

‘Major milestone’ for UK clinical trials as new framework laid in parliament

News

UK desirability has turned a corner in clinical trials

News

Merus’ Bizengri granted FDA accelerated approval to treat NRG1+ cancers

News

Four oral GLP-1R products in Phase III trials as race intensifies

News

Lead Gilead researcher highlights need for inclusive clinical trials for HIV

News

Dr Oz nominated to lead CMS despite big pharma ties

News

FDA shares additional draft guidance on CGTs

News

Trump 2.0 spells uncertainty for US healthcare, says analyst

News

Reeves’ 2024 budget promises life sciences investment

News

mRNA licensing agreements surge 800% amid GSK lawsuits

News

AstraZeneca eyes up transition to eco-friendly inhaler propellant

News

As mpox spreads, ‘national governments have a moral responsibility to help’

Jobs

Q2 2024 update: social responsibility related hiring actvity in the pharma industry

Jobs

Q2 2024 update: environmental sustainability related hiring actvity in the pharma industry

Features

What is mpox and how big of a threat is it?

News

Scientists push for ‘greener’ drugs in published study

Analysis

Psychedelic treatments for mental health: Is there substance behind the hype?

Data Insights

Q4 2023 update: environmental sustainability related M&A activity in the pharmaceutical industry

News

COP28 podcast: max 1.5°C temperature rise limit now ‘not possible’

News

COP28 podcast: max 1.5°C temperature rise limit now ‘not possible’

Features

Why COP28 was the first COP to truly align with climate science

Features

How COP28 raised the profile of ‘super pollutants’ like black carbon

News

“17 hours” to save climate conference as UAE publishes new COP28 outcome

Polly Bindman and Nick Ferris

Opinion

Germany’s COP28 message is undermined by its domestic climate action crisis

Features

Emirati oil casts an inescapable shadow over climate talks at COP28

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close